All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
The AML Global Portal were delighted to speak to Peter Valk, Erasmus University Medical Center, Rotterdam, NL, during the European School of Hematology (ESH) Translational Research Conference on AML. We asked Peter Valk: How do you integrate molecular diagnostics in clinical practice?
Peter Valk discusses the role of Next Generation Sequencing (NGS) in clinical decision- making in AML. He explains the important role of NGS in routine molecular-based diagnostics, prognostic and response monitoring such as measuring the presence or absence of whole genes and monitoring somatic and germline mutations.
How do you integrate molecular diagnostics in clinical practice?
Molecular diagnostics & therapeutics
The AML Hub are pleased to be covering the European School of Haematology (ESH) 2nd How to Diagnose and Treat: Acute Leukaemia meeting. Here, we review what was discussed at last year's meeting—ESH 5th...
ESH 2019 | How do genomic and epigenomic alterations synergize in AML?
Lars Bullinger explains that epigenetic mutations often predispose to leukemic events.
Subscribe to get the best content related to AML delivered to your inbox